Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Managing HIV infection. 2 new aspects].

C Katlama1

  • 1Service Pr. Bricaire, Groupe Hospitalier Pitié-Salpêtrière, Paris.

Presse Medicale (Paris, France : 1983)
|December 22, 1999
PubMed
Summary

Protease sparing regimens offer an alternative to standard HIV therapy, potentially improving tolerance. This approach is crucial for patients with HIV/HCV co-infection, where hepatitis C accelerates liver disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uptake of drug-reduced antiretroviral strategies and impact on costs over 2015-22: experience from an HIV clinic in Paris, France.

The Journal of antimicrobial chemotherapy·2025
Same author

No virological failure in patients living with HIV with past NNRTI resistance-associated mutations switched to doravirine-containing regimens.

The Journal of antimicrobial chemotherapy·2025
Same author

A case series of intermittent nucleoside analogue-based (NA) regimen to maintain HBV virological suppression in coinfected HBV/HIV patients with suppressed viremia.

Infectious diseases now·2024
Same author

The burden of secrecy in the management of multimorbidity in older people living with HIV aged 70 and over.

AIDS care·2024
Same author

Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.

HIV medicine·2024
Same author

Comparison of HIV-Infected and Noninfected Patients Undergoing Bariatric Surgery: The ObeVIH Study.

Journal of acquired immune deficiency syndromes (1999)·2022

Area of Science:

  • Infectious Diseases
  • Hepatology
  • Virology

Background:

  • Standard HIV tritherapy using two nucleosidic reverse transcription inhibitors (NRTI) and a protease inhibitor (PI) faces challenges in patient tolerance and acceptability.
  • Hepatitis C virus (HCV) co-infection in individuals with HIV can significantly worsen long-term outcomes due to accelerated liver disease progression, including chronic hepatitis and cirrhosis.

Purpose of the Study:

  • To explore the potential benefits of protease sparing regimens as an alternative to standard HIV treatment regimens.
  • To address the specific challenges posed by HIV/HCV co-infection, where managing both viral infections is critical for patient survival.

Main Methods:

  • Evaluation of alternative antiretroviral therapy strategies.
  • Focus on replacing protease inhibitors (PI) with a third antiretroviral agent in HIV treatment regimens.
  • Consideration of patient tolerance and acceptability factors in regimen selection.

Main Results:

  • Protease sparing regimens may offer improved tolerance and acceptability compared to traditional tritherapy.
  • The study highlights the critical need for effective management strategies in HIV/HCV co-infected patients.
  • Replacing PIs could be a viable option for specific patient populations.

Conclusions:

  • Protease sparing regimens represent a promising alternative for improving adherence and outcomes in HIV management.
  • Effective management of HIV/HCV co-infection is paramount to prevent severe liver complications and ensure long-term survival.
  • Further research into optimizing antiretroviral strategies for co-infected individuals is warranted.

Related Experiment Videos